Allay Pharmaceuticals

ProSolus Inc., a subsidiary of Canoa Inc., specializes in the formulation and development of advanced transdermal and topical drug delivery systems. With a focus on high-barrier-to-entry products for various therapeutic categories, including pain management and cardiovascular care, ProSolus leverages its state-of-the-art laboratory and manufacturing facility in Miami, Florida, to deliver innovative solutions tailored to client needs. Backed by a leadership team with over 65 years of collective experience, ProSolus is committed to optimizing delivery methods without relying on exotic permeation enhancers. The company's comprehensive approach encompasses the entire product lifecycle, from formulation through to clinical and packaging stages, ensuring a customized experience for partners in the pharmaceutical industry. Generated from the website

ECI Pharmaceuticals is a leading company in the pharmaceutical industry, dedicated to upholding the highest standards in their operations. With a strong emphasis on quality and innovation, they continue to make significant contributions to the field. Located in Fort Lauderdale, Florida, ECI Pharmaceuticals specializes in manufacturing and research, showcasing their commitment to advanced laboratory practices. Their team is focused on delivering excellence in all aspects of their business, ensuring customer satisfaction and industry leadership. Generated from the website

Noven Pharmaceuticals core business resides in transdermal drug delivery. As a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products, the company s prescription patches are sold in more than 30 countries. Together with Novartis Pharmaceuticals Corporation, the company owns Novogyne Pharmaceuticals, a women s health products company. Among other products, Novogyne markets and sells Noven s Vivelle-Dot product, one of the smallest estrogen patches in the world and one of the most dispensed estrogen patches in the United States. Noven is committed to expanding available transdermal therapies for the benefit of patients, partners and shareholders. Noven Pharmaceuticals is headquartered in Miami.